0001179110-17-006329.txt : 20170501
0001179110-17-006329.hdr.sgml : 20170501
20170501194718
ACCESSION NUMBER: 0001179110-17-006329
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170427
FILED AS OF DATE: 20170501
DATE AS OF CHANGE: 20170501
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CymaBay Therapeutics, Inc.
CENTRAL INDEX KEY: 0001042074
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943103561
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7999 GATEWAY BLVD
STREET 2: SUITE 130
CITY: NEWARK
STATE: CA
ZIP: 94560
BUSINESS PHONE: 510-293-8800
MAIL ADDRESS:
STREET 1: 7999 GATEWAY BLVD
STREET 2: SUITE 130
CITY: NEWARK
STATE: CA
ZIP: 94560
FORMER COMPANY:
FORMER CONFORMED NAME: METABOLEX, INC.
DATE OF NAME CHANGE: 20090721
FORMER COMPANY:
FORMER CONFORMED NAME: METABOLEX INC
DATE OF NAME CHANGE: 19970710
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Shah Sujal
CENTRAL INDEX KEY: 0001588861
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36500
FILM NUMBER: 17802560
MAIL ADDRESS:
STREET 1: C/O CYMABAY THERAPEUTICS, INC.
STREET 2: 3876 BAY CENTER PLACE
CITY: HAYWARD
STATE: CA
ZIP: 94545
4
1
edgar.xml
FORM 4 -
X0306
4
2017-04-27
0
0001042074
CymaBay Therapeutics, Inc.
CBAY
0001588861
Shah Sujal
C/O CYMABAY THERAPEUTICS, INC.
7999 GATEWAY BLVD., SUITE 130
NEWARK
CA
94560
0
1
0
0
Interim CEO
Employee Stock Option (right to buy)
3.48
2017-04-27
4
A
0
90000
0
A
2027-04-26
Common Stock
90000
90000
D
The option vests in equal monthly installments over the eight-month period beginning on the vesting commencement date of April 15, 2017, subject to the Reporting Person's continuous service to the Issuer.
/s/ Sujal Shah
2017-05-01